Disease Info Card

Uterine Cervical Neoplasm

Information about Uterine Cervical Neoplasm: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.

Overview of Uterine Cervical Neoplasm

Most recent studies have shown that Uterine Cervical Neoplasm shares some biological mechanisms with adenocarcinoma, carcinoma, carcinoma-in-situ, cervical-dysplasia, cervical-intraepithelial-neoplasia, dysplasia, intraepithelial-neoplasia, lymphatic-metastasis, malignant-neoplasms, malignant-paraganglionic-neoplasm, malignant-squamous-cell-neoplasm, malignant-tumor-of-cervix, mammary-neoplasms, neoplasm-metastasis, neoplasm-recurrence-local, neoplasms, ovarian-neoplasm, papillomavirus-infections, tumor-virus-infections, uterine-neoplasms.

Among the many pathways, these few ones have gauged particular interests from scientists studying Uterine Cervical Neoplasm, and have been seen in publications frequently: Angiogenesis, Cell Cycle, Cell Cycle Arrest, Cell Death, Cell Differentiation, Cell Growth, Cell Proliferation, Coagulation, Dna Methylation, Immune Response, Induction Of Apoptosis, Localization, Menopause, Methylation, Mitosis, Oncogenesis, Pathogenesis, Secretion, Transport, Transposition

Quite a number of genes have been found to play important roles in Uterine Cervical Neoplasm, such as ASAP1, ASAP2, CDKN1A, CDKN2A, EGFR, FAM49B, MRPS30, PAPOLA, PDAP1, PDXP, PMEL, REG3A, SERPINB3, TNF, TP53, TUSC2, VEGFA. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.

In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.